Avesta Pharma Private Limited

Avesta Pharma Private Limited - manufacturing in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH2009PTC192677 Incorporated 25 May 2009 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company manufacturing MSME · Medium
Data last updated
Revenue · FY 2025
₹202.35 Cr
▲ 25% YoY
Net profit · FY 2025
₹44.56 Cr
Net margin 22%
EBITDA · FY 2025
₹85.33 Cr
EBITDA margin 42.2%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹55.9 Cr
Satisfied ₹25.91 Cr
Company age
17 yrs
Est. 2009
Employees · EPFO
124
Provident fund records

About Avesta Pharma Private Limited

Data last updated:

Avesta Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the plastic and resins segment of the manufacturing sector. It was incorporated on 25 May 2009 and has been in existence for over 17 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2009PTC192677. Its GSTIN is 27AAHCA7372B1ZS (Maharashtra).

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Eric Kersi Tangri and Zubin Keki Gandhi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 106 / 108 Shivam Chambers 1st Floor S.V.Road Goregaon West, Mumbai, Maharashtra, India – 400062.

As per the financials filed for FY 2025, the company reported a revenue of ₹202.35 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹44.56 Cr (net margin 22%) and EBITDA of ₹85.33 Cr (EBITDA margin 42.2%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 37% over five years.

The company has about 124 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹55.9 Cr and satisfied charges of ₹25.91 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹1.99 Cr; the latest was in June 2012. The company has 53 MSME Form 1 returns on record between 2015 and 2024, listing 3,085 overdue payments to 217 micro and small suppliers.

Avesta Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0020687). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website avestapharma.net.

Company details

CIN U24239MH2009PTC192677
Registration Number 192677
Incorporation Date 25 May 2009
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-17-0020687
Key People
Eric Kersi Tangri Director Zubin Keki Gandhi Director Amol Ashok Walke Director

Recognitions & Rankings of Avesta Pharma

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-17-0020687

Contact details

Avesta Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is avestapharma.net. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    avestapharma.net
  • Registered Address
    106 / 108 Shivam Chambers 1st Floor S.V.Road Goregaon West, Mumbai, Maharashtra, India – 400062
  • Industry
    Manufacturing, Plastic & Resins

To see the full contact details of Avesta Pharma Private Limited, buy the company report.

Comprehensive company report
Avesta Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Avesta Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Avesta Pharma Private Limited, buy the company report.

Financials of Avesta Pharma Private Limited

FY 2025 filings available

Avesta Pharma Private Limited reported revenue of ₹202.35 Cr (up 25% YoY) for FY 2025.

Revenue · FY 2025
₹202.35 Cr ▲ 25%
Net profit · FY 2025
₹44.56 Cr margin 22%
EBITDA · FY 2025
₹85.33 Cr margin 42.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 28%
5 years · compounded
▲ 37%
EBITDA CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 53%
5 years · compounded
▲ 50%

Revenue has grown at a compounded annual rate (CAGR) of 37% over five years, including 25% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹85.33 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹44.56 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin42.2%
Net Profit Margin22%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Avesta Pharma Private Limited, buy the company report.

Board of directors of Avesta Pharma Private Limited

Avesta Pharma has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Eric Kersi Tangri
Also directs: Hildose Pharmaspecialities LLP, Enkad Trading LLP
Director01 Mar 20242 Years 7 MonthsCurrent
Zubin Keki Gandhi
Also directs: Venus Ethoxyethers Pvt Ltd, Grand Organics Private Limited, Dyna Glycols Private Limited and 4 more
Director30 Nov 200916 Years 11 MonthsCurrent
Amol Ashok Walke
Also directs: Walke Enterprises Limited Liability Partnership, Venus Ethoxyethers Pvt Ltd, Grand Organics Private Limited and 5 more
Director01 Apr 201511 Years 6 MonthsCurrent
Mahesh Hakmichand Doshi
Also directs: Accusynth Speciality Chemicals Private Limited
Director01 Apr 201511 Years 6 MonthsCurrent
Kersi Homi Tangri
Also directs: Accusynth Speciality Chemicals Private Limited, Hildose Pharmaspecialities LLP, Firoze Estates Private Limited and 2 more
Director25 May 200917 Years 5 MonthsCurrent
View all directors

Auditor

Avesta Pharma Private Limited is audited by Y. K. Desai & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Y. K. Desai & Co.FY 2023102370W

Shareholding

The shareholding of Avesta Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Avesta Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹55.9 Cr
Satisfied charges
₹25.91 Cr
Breakdown by lending institutions
Others₹55.90 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
03 Aug 2021100480251Others₹55.9 CrOpen
18 Aug 201110310331Bank of India₹18 CrSatisfied
18 Aug 201110310347Bank of India₹7.91 CrSatisfied

To see the full charge records of Avesta Pharma Private Limited, buy the company report.

Total charge records: 3 View all charges

Deals & funding

Avesta Pharma Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹1.99 Cr; the latest was in June 2012.

Total deals
2
Funding rounds
2
Disclosed funding
₹1.99 Cr

Deals on record (2 of 2)

WhenDealAmountParties
Jun 2012Funding round₹1.89 CrInvestors: 4 individuals
Mar 2010Funding round₹10 LakhInvestors: 4 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Avesta Pharma Private Limited has 53 MSME Form 1 returns on record between 2015 and 2024, listing 3,085 overdue payments to 217 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 217)

SupplierAmount dueDue sinceReported on
Bombay Pharma Equipments Private Limited
an individual supplier
an individual supplier
an individual supplier
an individual supplier

To see the full MSME payment records of Avesta Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Avesta Pharma Private Limited has a workforce of 124 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
124
Active EPFO establishments
1
Employee growth
25.25%

GST

Avesta Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAHCA7372B1ZSMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Avesta Pharma Private Limited, buy the company report.

Recent activity

Avesta Pharma Private Limited has 9 board changes on record since 2009: 5 appointments and 4 cessations. The latest: Eric Kersi Tangri ceased to be Additional Director on 29 Sep 2024.

AGM
Avesta Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Avesta Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Eric Kersi Tangri ceased to be Additional Director.
Appointed
Eric Kersi Tangri was appointed as Director.
Charges
A charge with Others of Rs. 55.90 Cr registered on 03 Aug 2021 with Charge ID 100480251 was modified on 15 Mar 2023.
Charges
A charge with Others amounted to Rs. 55.90 Cr with Charge ID 100480251 was registered on 03 Aug 2021.
Charges
A charge registered on 18 Aug 2011 via Charge ID 10310347 with Bank Of India was fully satisfied on 12 Jul 2021.
Charges
A charge registered on 18 Aug 2011 via Charge ID 10310331 with Bank Of India was fully satisfied on 29 Jan 2021.
Charges
A charge with Bank Of India of Rs. 7.91 Cr registered on 18 Aug 2011 with Charge ID 10310347 was modified on 12 Jan 2021.
Ceased
Amol Ashok Walke ceased to be Additional Director.
Ceased
Mahesh Hakmichand Doshi ceased to be Additional Director.
Appointed
Amol Ashok Walke was appointed as Director.

8 earlier events are in the company report.

Frequently asked questions

Avesta Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in plastic and resins, within the manufacturing industry. It was incorporated on 25 May 2009 (17+ years old) and is registered under CIN U24239MH2009PTC192677.

Avesta Pharma has 5 current directors:

The latest financial statements of Avesta Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Avesta Pharma is 27AAHCA7372B1ZS, registered in Maharashtra.

The CIN (Corporate Identification Number) of Avesta Pharma is U24239MH2009PTC192677. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Avesta Pharma has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending.

Avesta Pharma was incorporated on 25 May 2009, making it 17+ years old. It is registered with the Registrar of Companies, Mumbai.

Avesta Pharma has 2 deals on record (2 funding rounds), with disclosed funding of ₹1.99 Cr; the latest was in June 2012.

Eric Kersi Tangri ceased to be Additional Director on 29 Sep 2024. Eric Kersi Tangri was appointed as Director on 01 Mar 2024. Amol Ashok Walke ceased to be Additional Director on 30 Sep 2016. Avesta Pharma has 9 board changes on record in total.

Yes, Avesta Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-17-0020687).

Avesta Pharma has 53 MSME Form 1 returns on record between 2015 and 2024, listing 3,085 overdue payments to 217 micro and small suppliers. The latest return was filed on 26 Apr 2024.